First Horizon Advisors Inc. decreased its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 171,841 shares of the company’s stock after selling 1,256 shares during the period. AbbVie makes up 0.9% of First Horizon Advisors Inc.’s holdings, making the stock […]
AbbVie (NYSE:ABBV – Free Report) had its price target reduced by Barclays from $195.00 to $187.00 in a research report released on Monday morning, Benzinga reports. Barclays currently has an overweight rating on the stock. A number of other research analysts have also issued reports on ABBV. Guggenheim lifted their target price on AbbVie from […]
Brooktree Capital Management lowered its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,647 shares of the company’s stock after selling 106 shares during the quarter. AbbVie comprises […]
Brooktree Capital Management lessened its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,647 shares of the company’s stock after selling 106 shares during the period. AbbVie makes […]
FFT Wealth Management LLC grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 5.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,390 shares of the company’s stock after buying an additional 115 shares during the quarter. FFT Wealth Management LLC’s […]